Table 2.

vaccine candidates based on RNA platform for COVID-19 according to the WHO as of April 20, 2020 (adapted from (20).

Type of candidate vaccine	developer	stage of clinical evaluation
LNP-encapsulated mRNA(mRNA-1273)	USA (Moderna/NIAI)	Phase 2 (NCT04283461)
LNP-encapsulated mRNA cocktail encoding VLP	Fudan University/ Shanghai JiaoTong University/RNACure Biopharma	preclinical
mRNA	China CDC/Tongji University/Stermina	preclinical
mRNA	Arcturus/Duke-NU	preclinical
mRNA	BioNTech/Fosun Pharma/Pfizer	preclinical
saRNA	Imperial College London	preclinical
mRNA	Curevac	preclinical